tiprankstipranks
Trending News
More News >
Karyopharm Therapeutics (KPTI)
NASDAQ:KPTI
US Market

Karyopharm Therapeutics (KPTI) Balance Sheet

Compare
1,205 Followers

Karyopharm Therapeutics Balance Sheet

Karyopharm Therapeutics's total assets for Q3 2025 were $96.23M, a decrease of -8.24% from the previous quarter. KPTI total liabilities were $365.49M for the fiscal quarter, a 6.31% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Assets
$ 164.42M$ 240.44M$ 358.17M$ 305.31M$ 313.05M
Total Liabilities
$ 350.44M$ 376.64M$ 374.83M$ 384.98M$ 262.50M
Total Equity Gross Minority
$ -186.02M$ -136.21M$ -16.66M$ -79.67M$ 50.55M
Other Metrics
Currency in USD

Karyopharm Therapeutics Debt to Assets